• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, December 31, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Adults with type 2 diabetes face high risk of dying from cancer

Bioengineer by Bioengineer
July 3, 2019
in Cancer
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Cancer has overtaken cardiovascular disease as the most common cause of death in Scottish adults with type 2 diabetes, according to a study published in the Journal of Diabetes Investigation.

Investigators examined the causes of death of people with type 2 diabetes in Ayrshire and Arran, Scotland between 2009 and 2014 and compared them with national mortality rates. The most common cause of death was cancer (27.8%) followed by heart disease (24.1%).

The study’s results confirmed an increased risk of early death in individuals with type 2 diabetes compared with the general population, and they suggested that where cardiovascular risk factors are being treated aggressively, cancer takes on a greater importance in the cause of death.

###

Media Contact
Penny Smith
[email protected]
http://dx.doi.org/10.1111/jdi.13067

Tags: cancerCardiologyDiabetesMedicine/HealthMetabolism/Metabolic DiseasesPublic Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Derazantinib Boosts Gemcitabine by Blocking MUC5AC

December 30, 2025

FOCUS Study Reveals Insights on Melphalan for Uveal Melanoma

December 29, 2025

Black Grape Anthocyanins Boost 5-FU Cancer Therapy

December 29, 2025

Girdin Silencing Boosts Mebendazole’s Ovarian Cancer Fight

December 29, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    PTSD, Depression, Anxiety in Childhood Cancer Survivors, Parents

    101 shares
    Share 40 Tweet 25
  • NSF funds machine-learning research at UNO and UNL to study energy requirements of walking in older adults

    71 shares
    Share 28 Tweet 18
  • Exploring Audiology Accessibility in Johannesburg, South Africa

    52 shares
    Share 21 Tweet 13
  • Nurses’ Views on Online Learning: Effects on Performance

    71 shares
    Share 28 Tweet 18

About

BIOENGINEER.ORG

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Neocortical Neuron Identity Emerges Independently of Position

Study Reveals Neonatal MIS-N Linked to Maternal COVID-19

TP53-LGALS4 Axis Enhances Anti-PD-L1 Colorectal Cancer Therapy

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 71 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.